Chris – I just realized I had a brain cramp on that answer, confusing our VR stocks with our Smart Car portfolio; my apologies. In the case of VR, I think last week’s announcement by Google that is partnering with IMAX to create the next generation of 3D cameras may turn out to be a catalyst for many VR companies, including the three you mentioned. In addition to producing this camera, IMAX will also be opening several “entertainment hubs” around the country that will give people the chance to watch a ten minute video shot by these cameras that will give them the full impact of a VR type of experience. I think once enough people have done that, they will realize that VR isn’t a gimmick and will begin to appreciate the wide variety of commercial applications that this type of technology can facilitate. Two of those entertainment hubs will be opening later this year, and you can be sure there will be a lot of media coverage when it happens. That should also draw a lot of attention to many undiscovered VR stocks, so it may not be long before we start seeing some strong price movement in these companies. Jim

Yes. Please look in My Account at the top right of the BTP website to confirm we have your proper email address on file. If yes, please do the usual hunting in your junk email folders. If still unsuccessful, please contact our customer service team to hunt down the problem.

Hi Mota. At the moment OFI is the only service that sends alerts via text due to the extremely volatile nature of options, but we do send alerts via email so you should be able to pull those up on your phone as well. As a publisher we are prohibited from giving personalized advice so I can’t address the specifics of your situation, but we do advise buying our special situations stocks in bundles to minimize risk, and not putting too much money into any one of them, both of which you seem to be doing. Thank you. Jim

Hi Paul, and thank you for renewing your Wealth Society membership. The buy limits for all of our Special Situations portfolio stocks, including the three virtual reality companies, can be found under the Portfolios tab at the top of this page (http://www.investingdaily.com/breakthrough-tech-profits/portfolio/dynamic/special-situations/). Jim

As described in the Special Report under the Resources tab at the top of this page, Argos Therapeutics (ARGS) and Juno Therapeutics (JUNO) are the two cancer immunotherapy companies that we recommend (http://www.investingdaily.com/res/reports/term1y/BTP-One_Little_Shot_to_Kill_Cancer_Dead.pdf).

Good question. Although a secondary offering of common stock is dilutive to existing shareholders (which is a bad thing, all other things being equal), if the money is being raised so the company can increase production, acquire patents, etc., then the overall impact on the stock can be positive. You’ll notice that MVIS is up more than 2% today, suggesting this shelf registration does not trouble shareholders enough for them to bail out of the stock. None of the company’s officers or directors have sold any stock over the past year, either. We see no reason to change our opinion on MVIS based on this development. Thank you.

I read you answer to a similar question from another subscriber just now. If you have nothing further to add then disregard my post.